Centene/$CNC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Centene
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
- Ticker
- $CNC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 61,100
- Headquarters
- Saint Louis, United States
- Website
- www.centene.com
Centene Metrics
BasicAdvanced
$37B
25.13
$2.95
1.13
-
Price and volume
Market cap
$37B
Beta
1.13
52-week high
$78.08
52-week low
$31.63
Average daily volume
5.1M
Financial strength
Current ratio
1.164
Quick ratio
1.123
Long term debt to equity
0.693
Total debt to equity
0.697
Interest coverage (TTM)
5.46%
Profitability
EBITDA (TTM)
4,692
Gross margin (TTM)
11.34%
Net profit margin (TTM)
0.81%
Operating margin (TTM)
1.92%
Effective tax rate (TTM)
23.91%
Revenue per employee (TTM)
$2,950,000
Management effectiveness
Return on assets (TTM)
2.68%
Return on equity (TTM)
6.74%
Valuation
Price to earnings (TTM)
25.13
Price to revenue (TTM)
0.203
Price to book
1.65
Price to tangible book (TTM)
5.01
Price to free cash flow (TTM)
9.272
Free cash flow yield (TTM)
10.79%
Free cash flow per share (TTM)
8
Growth
Revenue change (TTM)
7.60%
Earnings per share change (TTM)
-127.64%
3-year revenue growth (CAGR)
8.99%
10-year revenue growth (CAGR)
18.57%
3-year earnings per share growth (CAGR)
-12.66%
10-year earnings per share growth (CAGR)
8.04%
What the Analysts think about Centene
Analyst ratings (Buy, Hold, Sell) for Centene stock.
Analyst projections of the future price of Centene stock.
Bulls say / Bears say
The Medicare turnaround is ahead of plan: Centene said it is on track for Medicare Advantage break-even in 2026, a year early, while its Part D membership and margins improved. These businesses offer earnings support as the company works through pressure in Medicaid and Marketplace. (Centene, Reuters)
Centene’s Illinois subsidiary was selected to continue serving the state’s HealthChoice Illinois Medicaid programme under a four-year contract starting in 2027. The award secures a sizeable existing member base and reinforces the company’s position in a core government-sponsored market. (PR Newswire)
Marketplace membership dropped to 3.4 million from 5.8 million a year earlier, and commercial revenue fell 21% in Q3. The shrinking book reflects affordability and subsidy changes, and may limit revenue even if pricing improves margins. (Centene, The Wall Street Journal)
The outlook faces further uncertainty from 2027 Medicaid work requirements and rate-setting: fewer healthier members could raise the cost of those who remain, while state rates may not adjust quickly enough. Centene also expects a California policy change to remove about 175,000 members from its managed-care rolls. (SEC, Centene)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.
Centene Financial Performance
Revenues and expenses
Centene Earnings Performance
Company profitability
Upcoming events
No upcoming events
Centene News
AllArticlesVideos
Funds containing Centene
AllUSDEURGBP
Fund name | Fund size | $CNC weighting |
|---|---|---|
iShares Global High Yield Corporate Bond$HYLD | $963M | 0.78% |
iShares Global High Yield Corporate Bond£IGHY | $963M | 0.78% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.55% |
Invesco Health Care S&P US Select Sector$XLVS | $552M | 0.50% |
Invesco Health Care S&P US Select Sector£XLVP | $552M | 0.50% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.